Fuller H B Co SEC Filings

Michael J. Happe, a director of H.B. Fuller Company (FUL), reported transactions on 08/29/2025. He disposed of 1,343 shares of common stock. The filing also reports acquisition of 450.45 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares and will convert on retirement, death, disability or certain specified events, subject to holding periods. The reported holdings after the transactions equal 13,390.71 shares beneficially owned, which includes stock units credited as dividend equivalents. The form was signed by an attorney-in-fact on 09/02/2025.

H.B. Fuller director Thomas W. Handley reported changes in beneficial ownership dated 08/29/2025. The filing shows a disposition of 1,347.1 shares of common stock and the acquisition of 540.54 stock units under the Directors' Deferred Compensation Plan. Those units convert 1-for-1 into common shares and will convert upon retirement, death, disability or certain specified events, subject to applicable holding periods. The filing reports 75,781.26 shares beneficially owned following the reported transactions. The Form 4 was signed by an attorney-in-fact on 09/02/2025.

Daniel L. Florness, a director of H.B. Fuller Company (FUL), reported insider transactions dated 08/29/2025. The Form 4 discloses a disposition of 1,351 shares of common stock and the acquisition of 360.36 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares upon retirement, death, disability or certain events. The filing reports 28,794.88 shares beneficially owned following these transactions, which includes units received as dividend equivalents. The Form 4 was signed by an attorney-in-fact on 09/02/2025. All transactions are recorded as direct ownership.

H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.

H.B. Fuller insider filing: Ms. Heather Campe, Senior Vice President, International Growth, reported transactions dated 08/15/2025. The filing shows a disposition of 22,316.23 shares of common stock in the non-derivative table. On the same date she acquired 36.77 phantom units that convert 1-for-1 into common stock under the company deferred compensation plan and acquired 36.77 underlying shares at an indicated price of $58.97. The report also lists multiple outstanding employee stock options (with strike prices $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) and restricted stock units vesting over 2026–2028, with specific share amounts disclosed for each grant. The form is signed by an attorney-in-fact on 08/18/2025.

Joao Magalhaes, Sr. VP, Engineering Adhesives at H.B. Fuller (FUL), reported an employee option exercise and an offsetting share sale on 08/08/2025. He exercised 1,099 fully vested options with a $33.38 exercise price and sold 1,099 shares at $56.315. Following these transactions his direct beneficial ownership declined from 4,384 shares to 3,285 shares. Table II lists multiple outstanding option grants and restricted stock units, including an 8,853-share option at a $61.30 strike and RSU grants of 130.22, 301.33 and 1,562.29 shares (some RSUs include dividend-equivalent reinvestment). The Form 4 documents a routine exercise and sale and provides the current option and RSU holdings disclosed by the reporting person.

The Form 144 for H.B. Fuller Company reports a proposed sale of 1,099 common shares through Charles Schwab with an aggregate market value of $61,890, to be sold approximately on 08/08/2025 on the NYSE. The filing states these shares were acquired on 08/08/2025 via an employee stock option exercise, with payment described as a broker payment for cashless exercise.

The notice also discloses a recent sale of 1,046 shares on 08/07/2025 generating gross proceeds of $58,787. The signer represents they do not possess any undisclosed material adverse information. Several filer-identification fields in the provided text are blank.

Form 4 discloses that H.B. Fuller (FUL) Senior Vice President of Engineering Adhesives, Joao Magalhaes, executed and immediately sold option-derived shares on 08-07-2025.

• Option exercise: 1,046 employee stock options exercised at $34.43.
• Open-market sale: 1,046 common shares sold the same day at a weighted-average $56.2022 (price range $56.09-$56.275).
• Direct holdings after sale: 3,285 common shares.
• Equity incentives still held: 29,949 vested/unvested options (exercise prices $33.38-$77.72) and 1,994 restricted stock units, most vesting between 2024-2028.

The transaction represents a 24.1 % reduction in Magalhaes’ directly held common stock (from 4,331 to 3,285 shares), yet he retains substantial equity exposure through options and RSUs. No 10b5-1 plan box was ticked, indicating discretionary timing. The sale is modest compared with FUL’s average daily volume and does not meaningfully alter insider ownership at the company level.